
Market Cap
₹ 5,211 Cr
P/E
—
Bearish
3
Neutral
8
Bullish
3
Bearish
3
Neutral
8
Bullish
35
Bearish
0
Neutral
0
Bullish
32
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
5,211 Cr
High Risk
—
30.8
—
15.9
1,740.00
740.05
Sales CAGR
1Y
62.32%
3Y
25.06%
5Y
22.02%
10Y
16.57%
Profit CAGR
1Y
-295.40%
3Y
-6.61%
5Y
25.57%
10Y
5.98%
ROE
TTM
-19.58%
3Y
3.48%
5Y
4.20%
10Y
5.83%
ROCE
TTM
-9.69%
3Y
5.00%
5Y
5.87%
10Y
8.49%
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Performance
MARKET LEADER
Valuation
OVERVALUED
Growth
SLUGGISH
Profitability
LOW MARGIN
Technicals
Bullish
Risk
MODERATE RISK
Turned 1 L into 11.27 L in last 5 Years
Fund Raising
2 days ago
Zota Health Care Limited Announces QIP Approval
Zota Health Care Limited approved the Qualified Institutions Placement (QIP) of equity shares during a Board meeting held on December 15, 2025.
Fund Raising Announcement
2 days ago
Zota Health Care QIP Announcement
Zota Health Care Limited announces the commencement of a Qualified Institutions Placement (QIP) of equity shares, with a floor price set at ₹ 1,615.28 per share.